Catalyst Wire Dossier Catalyst Wire Dossier

HER2-targeting vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HER2-targeting vaccine, covering 2017-05-15 to 2017-05-15. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer [Phase 1]

See pricing